In 4Q24, construction performance is expected to improve, though earnings may be tempered by lower equity income. In 2025, growth will be driven by ongoing projects, the Orange Line (West) starting in 1H25 and the Double Deck project (expected to be signed in 1Q25), supported by healthy gross margins and equity income growth. CK is trading at an undemanding valuation. Maintain BUY. Target price: Bt27.30.
1QFY25: Profits Deemed In line. Looking Forward To A “Rocketing” O&G, New Energy And Digital (Satellite Launch) Era 1QFY25 core profit deemed in line despite accounting for 19% of our/consensus full-year forecasts. We had expected a weak quarter especially from the O&G segment, due to lower activities especially from the well services, as the industry was in the midst of transitioning from the legacy multi-year Integrated Well Services contract to the new Integrated Well Continuity Services (IWC...
1QFY25: Landing Weaker Numbers SPTOTO’s 1QFY25 results were below expectations despite fewer draw days and weaker HR Owen performances. We expect SPTOTO to continue delivering steady earnings in the subsequent quarters, offering an attractive prospective yield of c.8% in FY25. Meanwhile, investors’ sentiment should recover and investors should focus on the group’s discounted valuations, especially when the political landscape has largely stabilised after the state elections. Maintain BUY with a ...
9M24: Results Within Expectations; Expect Decent 4Q24 Finish To The Year 9M24 core net profit of RM1,029m (+47% yoy) is largely in line with expectations. 3Q24 core EBIT rose 21% qoq, driven by better upstream results despite core profit falling 9% qoq on higher tax expenses. 4Q24 results are expected to rise sequentially due to higher CPO and PK selling prices. Maintain HOLD and target price of RM4.75. SDG will host its 3Q24 analyst briefing on 21 Nov 24, 2pm MYT.
As we continue to expect market volatility, we maintain exposure to names that have resilient earnings or are expected to enjoy an earnings growth recovery, such as Ausnutria Dairy (1717 HK), CSPC (1093 HK) and Dongfeng Motor (489 HK), and add PICC P&C (2328 HK) to our BUY list.
The stronger-than-expected 1Q19 economic data and central bank backstop have fuelled optimism that cycles are a thing of the past. With animal spirits rekindled, our more cautious view since end-February has not played out well. Although we have not seen an improvement in risk-reward so far and further meaningful monetary easing will be needed to see a sustainable recovery, we are adjusting our strategy to include laggards and policy-supported sectors in our BUY list.
The stronger-than-expected 1Q19 economic data and central bank backstop has fuelled optimism that cycles are a thing of the past. With animal spirits rekindled, our more cautious view since end-February has not played out well. Although we have not seen an improvement in risk-reward so far and further meaningful monetary easing will be needed to see a sustainable recovery, we are adjusting our strategy to include laggards and policy-supported sectors into our BUY list.
KEY HIGHLIGHTS Results Xiaomi Corp (1810 HK/BUY/HK$28.80/Target: HK$33.50) Xiaomi’s 3Q24 adjusted net profit is a slight beat at Rmb6.3b, as its EV business continued to deliver positive surprises on both product mix and margins. Going forward, Xiaomi is expected to deliver robust sales growth and margin expansion across its smartphones, IoT and EV businesses on the back of competitive product launches and solid execution. Raise target price to HK$33.50 based on higher sales and margins assump...
KEY HIGHLIGHTS Economics Economic Activity October data showed signs of stabilisation, with industrial production slightly missing expectations at 5.3% yoy (-0.1ppt), while retail sales grew 4.8% yoy (+1.6ppt), well above forecasts. FAI ytd growth held steady at 3.4% yoy, although property FAI ytd deteriorated further, down to -10.3% yoy and below expectations. The unemployment rate saw a slight improvement. Overall, the real estate sector remains a key drag on economic performance. Results ...
KEY HIGHLIGHTS Small-mid Cap Highlight Modern Dental (3600 HK/NOT RATED/HK$3.68) We visited Modern Dental’s Dongguan factory. The global leader in the dental prosthetics industry has a unique global distribution network and strong cash conversion. The company targets to enhance its leadership through accelerated digitalisation, opportunistic M&As and comprehensive product portfolios. It also targets high single-digit revenue growth in 2024-25 and a 50% dividend payout ratio in the long run, vs...
KEY HIGHLIGHTS Strategy Alpha Picks: November Conviction Calls The HSI and MSCI China dropped 3.9% and 5.9% mom respectively in October, as investors took profit pending further details on the expected fiscal package. We expect the fiscal stimulus to have been largely priced in and will take profit on most outperformers. Our focus will be on stocks with specific catalysts in the near term. We are adding Hansoh Pharma, Sands China, CSCEC and BYDE to our BUY list. We add Sinopharm to our SELL li...
The key concerns of investors include the sustainability of the recent rally and potential fundamental changes upon policy rollout. We think a valuation repair is underway with the upcoming 11.11 campaign and 3Q/4Q24 results release as a critical juncture. Investors are also becoming increasingly optimistic on mega-cap names such as Tencent, Meituan, Alibaba and JD in view of a favourable regulatory backdrop and stabilised competitive environment. Maintain MARKET WEIGHT.
KEY HIGHLIGHTS Economics Money Supply A little less to cheer. Strategy Small-Mid Cap Biweekly Riding on the wave of AI PC; Thunder Software Technology is a beneficiary. Sector Internet 3Q23 results preview: Solid e-commerce ad growth to drive sector growth; potential positive surprise from online game grossing. Internet Muted growth acceleration from 11.11 campaign. Update Xtep International Holdings (1368 HK/BUY/HK$6.43/Target: HK$9.50) Revenue guidance revised down yet sales target mainta...